SomnoMed Upgrades Fiscal 2025 Revenue, EBITDA Guidance; Shares Soar 41%

MT Newswires23:58 ET

SomnoMed Ltd: FY25 Guidance Upgrade and Appointment of CFO

ASX17:38 ET · Announcements

Somnomed Wins US FDA Clearance for Sleep Disorder Product; Shares Jump 5%

MT NewswiresOct 6 20:40 ET

SomnoMed Ltd: Annual Report to shareholders

ASXSep 30 00:31 ET · Announcements

SomnoMed Price Target Raised 18% to A$0.42/Share by Wilsons

Dow JonesAug 28 19:00 ET · Ratings

2 Small ASX Healthcare Shares Sprouting Green After FY24 Results

The Motley FoolAug 27 22:48 ET